Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...
A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results